德国Olympus Advalytix   www.advalytix.com www.olympus-global.com
Advalytix公司位于德国慕尼黑，于2000年11月由Infineon Technologies和EJ Ventures共同出资建立。其核心技术―微流体技术建立在表面声波（SAW）和慕尼黑大学纳米技术原理的基础上，能使少至1nl的液体产生高效搅动。该公司从2003年4月开始推广的基于SAW技术的杂交仪，已被用户认可并得到广泛应用。
2005年4月，Advalytix公司被Olympus生命科学公司收购。
德国Olympus Advalytix 
Advalytix (headquartered in Munich, Germany, US office in Concord, MA) was founded in 2000 and acquired by Olympus in 2005. We are now the Advalytix team within Olympus Life Science Research Europa GmbH.
Advalytix is Olympus’ world wide competence centre for cell-based molecular biology. We focus on single cell molecular diagnostics, and the miniaturisation of diagnostic and biological tests for research and development. Our products uniquely link imaging technologies such as microscopy with nucleic acid analysis, enabling turnkey solutions with optimized instruments and reagents. We constantly expand our product portfolio for life science research and diagnostics.
Nov 2000: Company founded in Munich
March 2003: Introduced hybridization station ArrayBoosterTM featuring non-invasive mixing to accelarate the incubation of DNA and protein microarrays
Aug 2004: Opened US office in Concord, Mass.
Sept 2004: Introduced the AdvaWashTM automated wash system for DNA microarray and FISH applications
Nov 2004: Signed a licence agreement on non-invasive mixing with Olympus Life and Materials Science Europa GmbH
Mar 2005: Olympus Life and Materials Science Europa GmbH acquires 100% of the Advalytix AG shares
Jan 2006: Introduced 1 µL PCR platform AmpliGridTM designed for the amplification of DNA from single cells
Jan 2007: Introduced the PlateBoosterTM for non-invasive mixing of 96-, 384- and 1536-well microtiter plates
Apr 2007: Introduced polar body kit for the diagnosis of chromosomal aberrations
Summer 2007: Advalytix AG moves to the new centre of excellence for cell based molecular diagnostics in Munich/Grosshadern
Dec 2007: Advalytix becomes a brand of Olympus Life Science Research Europa GmbH